Find More Contacts for Morphic Therapeutic
Protected Content
Chairman
Director, Executive Management
1 email found 2 phone numbers found
View contacts for Morphic Therapeutic to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Contact Email info@morphictx.com
  • Phone Number (781)996-0955

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. The company offers the development of therapies for patients with immunological, fibrotic, neoplastic, and vascular diseases, focusing on creating

small molecule inhibitors of various integrin targets.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Biotechnology Acquired Companies With More Than 50 Employees
1,295 Number of Organizations • $120B Total Funding Amount • 3,579 Number of Investors
New England Companies With More Than 50 Employees (Top 10K)
9,961 Number of Organizations • $418.3B Total Funding Amount • 11,601 Number of Investors
United States Acquired Companies With More Than 100 Employees (Top 10K)
9,738 Number of Organizations • $845.9B Total Funding Amount • 19,379 Number of Investors
East Coast Companies (Top 10K)
9,938 Number of Organizations • $1.5T Total Funding Amount • 65,961 Number of Investors

M&A Details

Edit M&A Details Section
Morphic Therapeutic was acquired by Eli Lilly for $3.2B on Jul 8, 2024. This deal was done in Cash.

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Morphic Therapeutic's headquarters? Morphic Therapeutic is located in Waltham, Massachusetts, United States.Who invested in Morphic Therapeutic? Morphic Therapeutic has 11 investors including Pfizer Venture Investments and Novo Holdings.How much funding has Morphic Therapeutic raised to date? Morphic Therapeutic has raised
$510.5M
.When was the last funding round for Morphic Therapeutic? Morphic Therapeutic closed its last funding round on May 3, 2023 from a Post-IPO Equity round.Who are Morphic Therapeutic's competitors? Alternatives and possible competitors to Morphic Therapeutic may include Interius BioTherapeutics, Gritstone bio, and Georgiamune.